Daniel K. Treiber

9.8k total citations · 1 hit paper
24 papers, 3.3k citations indexed

About

Daniel K. Treiber is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Daniel K. Treiber has authored 24 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Hematology. Recurrent topics in Daniel K. Treiber's work include RNA and protein synthesis mechanisms (8 papers), RNA modifications and cancer (6 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Daniel K. Treiber is often cited by papers focused on RNA and protein synthesis mechanisms (8 papers), RNA modifications and cancer (6 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Daniel K. Treiber collaborates with scholars based in United States and United Kingdom. Daniel K. Treiber's co-authors include James R. Williamson, Patrick P. Zarrinkar, Lisa Wodicka, Pietro Ciceri, Jeremy P. Hunt, Gabriel Pallares, Mindy I. Davis, Michael Höcker, Sanna Herrgård and Martha Rook and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Daniel K. Treiber

24 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive analysis of kinase inhibitor selectivity

2011 1.6k citations Mindy I. Davis, Jeremy P. Hunt et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel K. Treiber United States	16	2.6k	710	561	443	287	24	3.3k
Brian D. Marsden United Kingdom	30	2.7k 1.1×	375 0.5×	642 1.1×	318 0.7×	303 1.1×	65	3.9k
Patrick P. Zarrinkar United States	21	3.4k 1.3×	804 1.1×	725 1.3×	1.3k 2.9×	434 1.5×	34	5.0k
O. Fedorov United Kingdom	41	4.4k 1.7×	462 0.7×	832 1.5×	1.2k 2.6×	731 2.5×	56	5.4k
Markus A. Seeliger United States	33	3.1k 1.2×	650 0.9×	792 1.4×	760 1.7×	561 2.0×	74	4.5k
Jeremy P. Hunt United States	9	1.8k 0.7×	713 1.0×	462 0.8×	781 1.8×	213 0.7×	10	2.7k
David C. Dalgarno United States	33	2.4k 0.9×	158 0.2×	828 1.5×	557 1.3×	353 1.2×	71	3.6k
Pietro Ciceri Spain	14	2.1k 0.8×	690 1.0×	388 0.7×	288 0.7×	189 0.7×	14	2.8k
Regine S. Bohacek United States	23	1.6k 0.6×	975 1.4×	384 0.7×	263 0.6×	800 2.8×	49	2.6k
Frank Boschelli United States	28	1.4k 0.5×	175 0.2×	581 1.0×	823 1.9×	654 2.3×	69	2.6k
Michele McTigue United States	18	1.7k 0.7×	143 0.2×	1.0k 1.8×	200 0.5×	388 1.4×	25	2.9k

Countries citing papers authored by Daniel K. Treiber

Since Specialization

Citations

This map shows the geographic impact of Daniel K. Treiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel K. Treiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel K. Treiber more than expected).

Fields of papers citing papers by Daniel K. Treiber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel K. Treiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel K. Treiber. The network helps show where Daniel K. Treiber may publish in the future.

Co-authorship network of co-authors of Daniel K. Treiber

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel K. Treiber. A scholar is included among the top collaborators of Daniel K. Treiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel K. Treiber. Daniel K. Treiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Metz, Peter, Howard Bregman, Rishi G. Vaswani, et al.. (2025). Highly Selective and Reversible STAT6 Inhibition Demonstrates Potential for Differentiated Efficacy and Safety Profile in Type 2 Allergic Inflammation. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1319–A1319. 2 indexed citations

Meyerson, Beth E., et al.. (2024). Dialing for doctors: Secret shopper study of Arizona methadone and buprenorphine providers, 2022. Journal of Substance Use and Addiction Treatment. 160. 209306–209306. 4 indexed citations

Asquith, Christopher R. M., Daniel K. Treiber, & William J. Zuercher. (2019). Utilizing comprehensive and mini-kinome panels to optimize the selectivity of quinoline inhibitors for cyclin G associated kinase (GAK). Bioorganic & Medicinal Chemistry Letters. 29(14). 1727–1731. 20 indexed citations

Ciceri, Pietro, Susanne Müller, Alison O’Mahony, et al.. (2014). Dual kinase-bromodomain inhibitors for rationally designed polypharmacology. Nature Chemical Biology. 10(4). 305–312. 261 indexed citations

Quinn, Elizabeth R., Lisa Wodicka, Pietro Ciceri, et al.. (2013). Abstract 4238: BROMOscan - a high throughput, quantitative ligand binding platform identifies best-in-class bromodomain inhibitors from a screen of mature compounds targeting other protein classes.. Cancer Research. 73(8_Supplement). 4238–4238. 15 indexed citations

Davis, Mindy I., Jeremy P. Hunt, Sanna Herrgård, et al.. (2011). Comprehensive analysis of kinase inhibitor selectivity. Nature Biotechnology. 29(11). 1046–1051. 1639 indexed citations breakdown →

Abraham, Sunny, Michael J. Hadd, Lan P. Tran, et al.. (2011). Novel series of pyrrolotriazine analogs as highly potent pan-Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(18). 5296–5300. 13 indexed citations

Wodicka, Lisa, Pietro Ciceri, Mindy I. Davis, et al.. (2010). Activation State-Dependent Binding of Small Molecule Kinase Inhibitors: Structural Insights from Biochemistry. Chemistry & Biology. 17(11). 1241–1249. 82 indexed citations

Patel, Hitesh, Robert M. Grotzfeld, Andiliy Lai, et al.. (2009). Arylcarboxyamino-substituted diaryl ureas as potent and selective FLT3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(17). 5182–5185. 26 indexed citations

10.

Young, Matthew A., Neil P. Shah, Luke H. Chao, et al.. (2006). Structure of the Kinase Domain of an Imatinib-Resistant Abl Mutant in Complex with the Aurora Kinase Inhibitor VX-680. Cancer Research. 66(2). 1007–1014. 211 indexed citations

11.

Fabian, Miles A., William Biggs, Daniel K. Treiber, Patrick P. Zarrinkar, & David J. Lockhart. (2005). Reply to BIRB-796 is not an effective ABL(T315I) inhibitor. Nature Biotechnology. 23(10). 1210–1211. 3 indexed citations

12.

Treiber, Daniel K. & James R. Williamson. (2001). Beyond kinetic traps in RNA folding. Current Opinion in Structural Biology. 11(3). 309–314. 162 indexed citations

13.

Treiber, Daniel K. & James R. Williamson. (2001). Concerted kinetic folding of a multidomain ribozyme with a disrupted loop-receptor interaction. Journal of Molecular Biology. 305(1). 11–21. 35 indexed citations

14.

Treiber, Daniel K. & James R. Williamson. (2000). [21] Kinetic oligonucleotide hybridization for monitoring kinetic folding of large RNAs. Methods in enzymology on CD-ROM/Methods in enzymology. 317. 330–353. 14 indexed citations

15.

Treiber, Daniel K. & James R. Williamson. (1999). Exposing the kinetic traps in RNA folding. Current Opinion in Structural Biology. 9(3). 339–345. 189 indexed citations

16.

Rook, Martha, Daniel K. Treiber, & James R. Williamson. (1998). Fast folding mutants of the Tetrahymena group I ribozyme reveal a rugged folding energy landscape 1 1Edited by D. Draper. Journal of Molecular Biology. 281(4). 609–620. 93 indexed citations

17.

Treiber, Daniel K., Martha Rook, Patrick P. Zarrinkar, & James R. Williamson. (1998). Kinetic Intermediates Trapped by Native Interactions in RNA Folding. Science. 279(5358). 1943–1946. 185 indexed citations

18.

Treiber, Daniel K. & James R. Williamson. (1995). A simple method for preparing pools of synthetic oligonucleotides with random point deletions. Nucleic Acids Research. 23(17). 3603–3604. 2 indexed citations

19.

Treiber, Daniel K., et al.. (1992). An ultraviolet light-damaged DNA recognition protein absent in xeroderma pigmentosum group E cells binds selectively to pyrimidine (6–4) pyrimidone photoproducts. Nucleic Acids Research. 20(21). 5805–5810. 60 indexed citations

20.

Donahue, Brian A., Steven F. Bellon, Daniel K. Treiber, et al.. (1990). Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin. Biochemistry. 29(24). 5872–5880. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact